AI-generated summary
The authors report on the potential of diversified ultraviolet irradiation, including UV-B, UV-C, far-UV, riboflavin-mediated phototherapy and photobiomodulation, as a non-invasive approach for neurodegenerative diseases. They describe preclinical models and early clinical trials showing preserved cognition, enhanced neurogenesis and reduced biomarkers. The abstract itself notes that optimal dosing, long-term safety and mechanisms remain to be investigated.
- Who or what was studied
- unclear
- Wavelengths
- 280, 320, 200, 280, 207, 222 nm
- Limits stated in the abstract
- The abstract states that optimal dosing, long-term safety and mechanistic pathways still require investigation, and it relies on preclinical models and early clinical trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Neurodegenerative diseases (NDs) such as Alzheimer's, Parkinson's, Huntington's disease, and amyotrophic lateral sclerosis are escalating worldwide, straining healthcare systems and leaving patients with therapies that are largely palliative. Emerging evidence positions diversified ultraviolet (UV) irradiation as a groundbreaking, non-invasive strategy to counter these disorders. Beyond its traditional use in sterilization, specific UV spectra, UV-B (280-320 nm), UV-C (200-280 nm), and far-UV (207-222 nm), are now recognized for modulating oxidative stress, restoring mitochondrial function, correcting apoptotic dysregulation, and enhancing DNA repair. Innovative approaches such as riboflavin-mediated phototherapy and photobiomodulation (PBM) show the capacity to disaggregate toxic protein aggregates like β-amyloid and α-synuclein, boost antioxidant defenses, stimulate neurotrophic factors, and quell neuroinflammation. Preclinical models and early clinical trials reveal preserved cognition, enhanced neurogenesis, and reduced disease biomarkers, suggesting real translational promise. From a public-health perspective, UV-based interventions offer a cost-effective, scalable option for aging populations and resource-limited settings, especially when integrated with community-level health technologies and remote delivery platforms. Continued investigation of optimal dosing, long-term safety, and mechanistic pathways will be pivotal to unlock the full therapeutic and population-wide impact of this novel modality.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 280-320 nm, 200-280 nm, 207-222 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Ultraviolet, Photobiomodulation, Neuroinflammation, Oxidative stress, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.